search icon
biocq-img

Biocept Inc., Common Stock

BIOCQ

PNK

$0.0001

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$262.00
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.66K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-35.61
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0 L
$0.06 H
$0.0001

About Biocept Inc., Common Stock

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBIOCQSectorS&P500
1-Week Return--1.67%1.25%
1-Month Return-99.83%-3.51%1.77%
3-Month Return--4.17%9.07%
6-Month Return--10.65%5.36%
1-Year Return--12.8%19.28%
3-Year Return-100%-2.49%48.86%
5-Year Return-100%21.6%88.54%
10-Year Return-100%72.94%205.26%

Financials

Dec '19Dec '20Dec '21Dec '22
Total Revenue5.53M27.46M61.25M25.86M[{"date":"2019-12-31","value":9.03,"profit":true},{"date":"2020-12-31","value":44.84,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":42.22,"profit":true}]
Cost of Revenue10.98M21.34M37.76M28.44M[{"date":"2019-12-31","value":29.07,"profit":true},{"date":"2020-12-31","value":56.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":75.31,"profit":true}]
Gross Profit(5.45M)6.12M23.48M(2.58M)[{"date":"2019-12-31","value":-23.2,"profit":false},{"date":"2020-12-31","value":26.08,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-10.99,"profit":false}]
Gross Margin(98.56%)22.30%38.34%(9.99%)[{"date":"2019-12-31","value":-257.04,"profit":false},{"date":"2020-12-31","value":58.16,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26.04,"profit":false}]
Operating Expenses17.61M21.59M25.89M29.40M[{"date":"2019-12-31","value":59.89,"profit":true},{"date":"2020-12-31","value":73.44,"profit":true},{"date":"2021-12-31","value":88.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true}]
Operating Income(23.06M)(15.47M)(2.41M)(31.98M)[{"date":"2019-12-31","value":-2305693900,"profit":false},{"date":"2020-12-31","value":-1546900000,"profit":false},{"date":"2021-12-31","value":-240900000,"profit":false},{"date":"2022-12-31","value":-3198300000,"profit":false}]
Total Non-Operating Income/Expense(2.33M)(2.57M)(580.00K)(545.00K)[{"date":"2019-12-31","value":-233108400,"profit":false},{"date":"2020-12-31","value":-257400000,"profit":false},{"date":"2021-12-31","value":-58000000,"profit":false},{"date":"2022-12-31","value":-54500000,"profit":false}]
Pre-Tax Income(25.14M)(17.81M)(2.70M)(32.21M)[{"date":"2019-12-31","value":-2513803900,"profit":false},{"date":"2020-12-31","value":-1780700000,"profit":false},{"date":"2021-12-31","value":-269900000,"profit":false},{"date":"2022-12-31","value":-3221200000,"profit":false}]
Income Taxes249.98K236.00K125.00K(125.00K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":94.41,"profit":true},{"date":"2021-12-31","value":50,"profit":true},{"date":"2022-12-31","value":-50,"profit":false}]
Income After Taxes(25.39M)(18.04M)(2.82M)(32.09M)[{"date":"2019-12-31","value":-2538802300,"profit":false},{"date":"2020-12-31","value":-1804300000,"profit":false},{"date":"2021-12-31","value":-282400000,"profit":false},{"date":"2022-12-31","value":-3208700000,"profit":false}]
Income From Continuous Operations(25.14M)(17.81M)(2.82M)(32.09M)[{"date":"2019-12-31","value":-2513803900,"profit":false},{"date":"2020-12-31","value":-1780700000,"profit":false},{"date":"2021-12-31","value":-282400000,"profit":false},{"date":"2022-12-31","value":-3208700000,"profit":false}]
Income From Discontinued Operations----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Net Income(25.14M)(17.81M)(2.82M)(32.09M)[{"date":"2019-12-31","value":-2513803900,"profit":false},{"date":"2020-12-31","value":-1780700000,"profit":false},{"date":"2021-12-31","value":-282400000,"profit":false},{"date":"2022-12-31","value":-3208700000,"profit":false}]
EPS (Diluted)(14.40)(1.89)-(42.41)[{"date":"2019-12-31","value":-1440,"profit":false},{"date":"2020-12-31","value":-189,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-4241,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BIOCQ
Cash Ratio 1.35
Current Ratio 1.81
Quick Ratio 1.70

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BIOCQ
ROA (LTM) -51.65%
ROE (LTM) -186.94%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BIOCQ
Debt Ratio Lower is generally better. Negative is bad. 0.99
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.01

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BIOCQ
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 3.65
EV/Ebitda NM

FAQs

What is Biocept Inc. share price today?

Biocept Inc. (BIOCQ) share price today is $0.0001

Can Indians buy Biocept Inc. shares?

Yes, Indians can buy shares of Biocept Inc. (BIOCQ) on Vested. To buy Biocept Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BIOCQ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biocept Inc. be purchased?

Yes, you can purchase fractional shares of Biocept Inc. (BIOCQ) via the Vested app. You can start investing in Biocept Inc. (BIOCQ) with a minimum investment of $1.

How to invest in Biocept Inc. shares from India?

You can invest in shares of Biocept Inc. (BIOCQ) via Vested in three simple steps:

  • Click on Sign Up or Invest in BIOCQ stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biocept Inc. shares
What is Biocept Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biocept Inc. (BIOCQ) is 0.00

What is the Market Cap of Biocept Inc.?

The market capitalization of Biocept Inc. (BIOCQ) is $262.00

What is Biocept Inc.’s stock symbol?

The stock symbol (or ticker) of Biocept Inc. is BIOCQ

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top